The total annual market for next generation cancer diagnostics was $776 million in 2010, and is growing at a compound annual growth rate (CAGR) of 47%, to reach a forecast market size of $5.3 billion in 2015.
Learn about the status of next generation cancer diagnostic technologies and assays, and assess their worldwide growth potential over a 5-year period from 2010 to 2015. Influencing factors, including cancer diagnostics needs, regulatory trends, industry structure, and patent status are also discussed…
Use this report to:
- Characterize the markets for the key next generation platforms: real time polymerase chain reaction, DNA microarrays, lab-on-a-chip, protein microarrays, circulating tumor cells, and multiplexed conventional and next generation sequencing.
- Understand the trends, markets, applications, industry dynamics, and the forces driving industry growth as the basis for effective strategy development.
- Evaluate market opportunities and future growth of specific cancer diagnostic market segments to validate or formulate business development plans.
- Analyze the impact of recent corporate acquisitions and alliances with the potential to change the industry structure and competitive landscape.
To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.